Chaperone-mediated autophagy (CMA) selectively degrades a subset of cytosolic proteins in lysosomes. A potent physiological activator of CMA is nutrient deprivation, a condition in which intracellular triglyceride stores or lipid droplets (LDs) also undergo hydrolysis (lipolysis) to generate free fatty acids for energetic purposes. Here we report that the LD-associated proteins perilipin 2 (PLIN2) and perilipin 3 (PLIN3) are CMA substrates and their degradation through CMA precedes lipolysis. In vivo studies revealed that CMA degradation of PLIN2 and PLIN3 was enhanced during starvation, concurrent with elevated levels of cytosolic adipose triglyceride lipase (ATGL) and macroautophagy proteins on LDs. CMA blockage both in cultured cells and mouse liver or expression of CMA-resistant PLINs leads to reduced association of ATGL and macrolipophagy-related proteins with LDs and the subsequent decrease in lipid oxidation and accumulation of LDs. We propose a role for CMA in LD biology and in the maintenance of lipid homeostasis.
Chaperone-mediated autophagy (CMA) selectively degrades a subset of cytosolic proteins in lysosomes. A potent physiological activator of CMA is nutrient deprivation, a condition in which intracellular triglyceride stores or lipid droplets (LDs) also undergo hydrolysis (lipolysis) to generate free fatty acids for energetic purposes. Here we report that the LD-associated proteins perilipin 2 (PLIN2) and perilipin 3 (PLIN3) are CMA substrates and their degradation through CMA precedes lipolysis. In vivo studies revealed that CMA degradation of PLIN2 and PLIN3 was enhanced during starvation, concurrent with elevated levels of cytosolic adipose triglyceride lipase (ATGL) and macroautophagy proteins on LDs. CMA blockage both in cultured cells and mouse liver or expression of CMA-resistant PLINs leads to reduced association of ATGL and macrolipophagy-related proteins with LDs and the subsequent decrease in lipid oxidation and accumulation of LDs. We propose a role for CMA in LD biology and in the maintenance of lipid homeostasis.
Autophagy maintains cellular homeostasis by degrading proteins, lipids and organelles in lysosomes 1, 2 . Turnover of non-functional cellular components by autophagy ensures quality control and recycling of degraded products provides energy 3 . In CMA, the heat shock cognate protein of 70 kDa (hsc70) recognizes proteins with a pentapeptide motif 4 and delivers them to the lysosome surface 5 for binding to lysosome-associated membrane protein 2A (LAMP-2A; L2A), the rate-limiting component of CMA (ref. 6) . L2A organizes into a multimeric complex 7 and in cooperation with lysosomal hsc70 (ref. 8) mediates lysosomal translocation of the unfolded substrates 9 for degradation. CMA occurs in most mammalian cell types 10, 11 and is maximally activated following prolonged starvation 12 , mild oxidative stress 13 , hypoxia 14 and lipogenic stressors 15 . A decrease in the lysosomal stability of LAMP-2A results in reduced CMA activity in old organisms 16, 17 . In addition to the well-characterized turnover of proteins by autophagy, lipids can also undergo degradation by macroautophagy, by sequestration into double-membrane vesicles (autophagosomes) that then fuse with lysosomes 18, 19 . Autophagy-mediated lipolysis (macrolipophagy) selectively targets LDs, intracellular lipid stores that serve as an energy source through hydrolysis of triglycerides into free fatty acids (FFAs). LDs are surrounded by structural proteins of the perilipin (PLIN) family, with PLIN1 being primarily an adipocyte protein and PLIN2 and PLIN3 expressed ubiquitously 20 . Lipolysis can occur through cytosolic lipases, such as ATGL (ref. 21) , or by lysosome luminal lipases when autophagosomes, formed through assembly of autophagy-related proteins (ATGs) on the LD surface, engulf portions of LDs and target them to lysosomes 18 . Although CMA can degrade only proteins and no lipids, mice with a constitutive blockage of CMA in the liver exhibit pronounced steatosis, even though non-selective macroautophagy was intact 22 . The discrete increase in lipogenesis, due to reduced degradation of lipogenic enzymes through CMA (ref. 22) , could not account alone for the massive hepatic lipid accumulation in these animals. This finding, combined with the facts that in tissues, such as the liver, lipid influx, lipolysis and CMA activation occur at maximal rates during starvation 12, 23 ; lipogenic challenges initially upregulate CMA activity 15 ; and conditions when CMA activity decreases such as ageing 16 often associate with intracellular lipid accumulation 24 , prompted us to further investigate the role of CMA in regulating lipid homeostasis.
Here, we demonstrate that blocking CMA both in cultured cells and in mouse liver in vivo decreases LD breakdown. Under conditions that promote lipolysis, CMA degrades the LD proteins PLIN2 and PLIN3, and this facilitates the LD association of cytosolic lipase ATGL and of macroautophagy ATGs. Reduced CMA precludes recruitment of the lipolytic machinery to the LDs, thereby positioning CMA as a critical upstream regulator of both macrolipophagy and cytosolic lipolysis.
RESULTS

LAMP-2A-deficient cells accumulate LDs
Using both, livers from mice conditionally knocked out for LAMP-2A (L2A) in hepatocytes 22 (L2AKO) and mouse fibroblasts (NIH3T3 cells) knocked down for L2A (L2A(−)) to block CMA (ref. 25) we confirmed that, despite the lower dependence of fibroblasts on lipid metabolism when compared with hepatocytes, L2A-deficient fibroblasts accumulated significantly more triglycerides than control fibroblasts (Fig. 1a) . These differences in triglyceride content were even higher when intracellular lipid usage was forced by reducing glucose in the media or after a lipogenic stimulus (oleate; OL; Fig. 1a) .
As in the L2AKO mice 22 , we found only a slight trend towards higher triglyceride synthesis in L2A(−) cells compared with control cells (Fig. 1b) . In contrast, L2A(−) cells showed significantly reduced β-oxidation rates, an event downstream of triglyceride hydrolysis, both under basal and lipogenic conditions (Fig. 1c) , and failed to increase oxygen consumption rates (OCRs) on OL exposure ( Fig. 1d ; CTR cells: 20.9 + 1.7 pmol min −1 ; L2A(−) cells: −1.3 + 0.2 pmol min −1 OCR change). Decreased β-oxidation rates in L2A(−) cells were not due to defective mitochondria per se, because the fraction of mitochondria with intact membrane potential ( Supplementary Fig. 1a ) and mitochondria turnover (detected with pH-sensitive MitoKeima reporter 26 ; Supplementary Fig. 1b ) were comparable to CTR cells. Differences in β-oxidation rates between control and L2A(−) cells were minimized in the presence of etomoxir (inhibitor of mitochondrial FFA uptake; Fig. 1d ; on OL addition, OCR in CTR cells was 48.4 + 2.1 pmol min −1 higher than in L2A(−) cells, but after adding etomoxir the difference between both cell types was reduced to 17.2 + 1.6 pmol min −1 ), suggesting a problem in lipid mobilization and not in its oxidation per se.
Consistent with the pronounced hepatosteatosis of L2AKO mice ( Supplementary Fig. 1c ), L2A(−) fibroblasts accumulate more and bigger lipid droplets visible with either BODIPY493/503 ( Fig. 1e and Supplementary Fig. 1d ) or DPH (1,6-diphenylhexatriene 27 ; Supplementary Fig. 1e,f) , both under basal and OL-treated conditions. Unlike control cells, etomoxir-treated L2A(−) cells failed to increase LDs, supporting defective lipid mobilization ( Supplementary Fig. 1g ). To further test this hypothesis, we used different experimental paradigms to force lipolysis in fibroblasts. OL-challenged control cells, on removal of OL (OL > S+) showed a decrease in LD number and size, even more evident when maintained in serum-free media (OL > S−; Fig. 1e and Supplementary Fig. 1d-f) . In contrast, OLchallenged L2A(−) cells maintained elevated LD number and size throughout. Similarly, culturing cells in low-glucose or in serum-free media, to facilitate cellular usage of lipid stores, revealed a significantly reduced ability of L2A(−) cells to decrease their triglyceride levels and LD content compared with control cells (Fig. 1a and Supplementary  Fig. 1h ). Electron microscopy confirmed that LD number, average size and occupied cellular area were significantly higher in CMAdeficient cells than in control cells in all conditions tested (Fig. 1f) . LD accumulation in L2A(−) cells was a direct consequence of L2A loss because expressing L2A in these cells ( Supplementary  Fig. 1i ,j) was sufficient to reduce LD to control cell levels (Fig. 1g) . Together, these results indicate that CMA blockage results in LD accumulation and this is primarily a consequence of decreased LD breakdown.
LD proteins PLIN2 and PLIN3 are CMA substrates As only proteins and not lipids can be CMA substrates, we next investigated a role for CMA in degradation of LD proteins, which could explain defective LD utilization in CMA-deficient cells. Immunoblotting ( Fig. 2a and Supplementary Fig. 2a ) and immunofluorescence ( Fig. 2b) for the ubiquitously expressed PLIN2 and PLIN3 showed significantly higher levels under basal, OL treatment and post-OL treatment in L2A(−) cells. Consistent with the described PLIN2 turnover by the ubiquitin-proteasome pathway 28, 29 , proteasomal inhibitors increased LD number (Supplementary Fig. 2b ) and PLIN2 levels ( Supplementary Fig. 2c ) in control cells but not in CMA-defective cells, although proteasomal degradation rates of ubiquitylated proteins and of a degron-GFP reporter 30 were preserved in these cells ( Supplementary Fig. 2c-e) . Lipid accumulation after proteasomal or lysosomal inhibition was comparable ( Supplementary  Fig. 2b ), leaving open the possibility that PLINs could also be amenable to lysosomal degradation.
To examine the possible contribution of CMA to PLIN2 and PLIN3 degradation, we first investigated their association with lysosomes. In support of PLIN lysosomal turnover, inhibiting lysosomal degradation with ammonium chloride and leupeptin in control cells significantly increased the co-localization of PLIN2 or PLIN3 with the lysosomal marker (LAMP1), and more so on OL addition (Fig. 2c,d and Supplementary Fig. 2f,g ). In contrast, L2A(−) cells showed decreased association of PLIN2 and PLIN3 with lysosomes and impaired flux with lysosomal inhibitors (Fig. 2c,d and Supplementary Fig. 2f,g ). , is shown as a positive control). Lysosomal levels of both PLINs were reduced in L2A(−) cells (Fig. 2f) . We confirmed that lysosomal association of PLIN2 and PLIN3 led to their degradation in vivo, because blocking lysosomal proteolysis in starved rats with leupeptin for 2 h was sufficient to increase levels of these LD proteins in CMA-active lysosomes ( Fig. 2g and Supplementary Fig. 2h ). CMA degradation of PLIN2 was also detected in fed mice, albeit at lower levels than in starved animals ( Fig. 2g) , whereas lysosomal degradation of PLIN3 in fed conditions was negligible (Fig. 2g) . Some degradation of PLINs was observed in CMA− lysosomes, probably due to LD degradation by macrolipophagy, because these lysosomes preferentially fuse with autophagosomes 33 . Collectively, results from our in vitro and in vivo studies indicate that CMA degrades PLIN2 and PLIN3.
PLINs interact with CMA chaperone hsc70
The first step in CMA is substrate interaction with hsc70 for subsequent lysosomal targeting. We found hsc70 in isolated rat liver LDs and its levels increased during starvation, when hepatic lipolysis is highly active, coinciding with a decrease in LD levels of PLIN2 and PLIN3 (Fig. 3a) . Immunofluorescence confirmed hsc70 co-localization with each PLIN on LDs, which increased on OL challenge that induces lipolysis (Fig. 3b,c and Supplementary  Fig. 3a ). Forcing lipid mobilization by placing cells in serumfree media post-OL challenge reduced association of hsc70 with LDs ( Supplementary Fig. 3b ). Remarkably, L2A(−) cells exhibited Graph: average LD number per cell (LD size shown in Supplementary  Fig. 1d ). n = 6 independent experiments with 40 cells per condition in each experiment. (f) Electron microscopy of cells treated as in e. Graphs: area occupied by LD or average LD number per cell and LD size. n = 3 independent experiments with 5 micrographs per condition. In e and f insets depict higher magnification images of lipid droplets. (g) DPH staining in CTR and L2A(−) cells transfected with hL2A, untreated or treated with OL. Asterisks: transfected cells. Graph: average LD number per cell calculated from orthoviews. n = 5 independent experiments with 40 cells per condition in each experiment. Values are mean ± s.e.m. Differences are significant for * P < 0.05, * * P < 0.01, * * * P < 0.001 using Student's t-test. Source data are available in Supplementary Table 1. higher hsc70 co-localization with PLIN2 or PLIN3 in LDs under all conditions (Fig. 3b,c and Supplementary Fig. 3a,b) . A similar higher abundance of hsc70 was also observed in LDs isolated from livers of L2AKO mice compared with control littermates (Fig. 3d) . We found direct interaction of hsc70 with PLIN2 and with PLIN3 in cultured cells. Hsc70 was recovered in PLIN2 and 3 pulldowns (Fig. 3e,f) and both PLINs were also detected in hsc70 pulldowns ( Supplementary Fig. 3c,d ). For the same amount of PLINs pulled down, we consistently observed higher levels of bound hsc70 in L2A(−) cells (Fig. 3e,f) . Increased binding to hsc70 is characteristic of CMA substrates in these cells where disruption of CMA occurs at the level of the lysosomal receptor (L2A) whereas substrate recognition and PLIN3 levels in leupeptin-treated CMA+ lysosomes relative to untreated. Representative blots from 3 independent experiments (the other two are shown in Supplementary Fig. 2h ). Values are mean ± s.e.m. Differences are significant for * P < 0.05, * * P < 0.01, * * * P < 0.001 using Student's t-test. Unprocessed original scans of blots are shown in Supplementary Fig. 8 . Source data are available in Supplementary Table 1 .
by hsc70 is intact ( Supplementary Fig. 3e shows the same effect in two other CMA substrates). This enhanced binding of hsc70 for multiple substrates explains why higher levels of PLINs (a single substrate) are not observed in hsc70 pulldowns ( Supplementary Fig. 3c,d ). by CMA (Fig. 3e ,f and Supplementary Fig. 3f ). As, contrary to the almost exclusive LD location of PLIN2, PLIN3 can be present in other cellular compartments, we isolated mouse liver LDs and confirmed that interaction of hsc70 with PLINs occurs in LDs (Fig. 3g) . These results are compatible with PLIN2 and PLIN3 being recognized by the CMA chaperone hsc70 at the LD surface before undergoing CMAmediated degradation.
Modifications of CMA-targeted PLINs
To further confirm the involvement of CMA in PLIN turnover, we activated CMA in OL-challenged cells using an atypical retinoic acid derivative 34 . Chemical activation of CMA significantly reduced PLIN2 levels ( Fig. 4a ) and LD content (Fig. 4b ) in control cells but not in L2A(−) cells. In fact, restoration of L2A levels in L2A(−) cells through transient transfection was sufficient to bring PLIN2 levels close to control cell values (Fig. 4b) .
To identify possible post-translational modifications that trigger PLIN2 for CMA degradation, we performed bidimensional electrophoresis and immunoblotting and found two very prominent forms of PLIN2 with isoelectric points of 5.6 and 5.9 and a less abundant isoform with an isoelectric point of 5.3. When lipolysis and subsequent PLIN2 degradation was induced with OL, the less positively charged isoform was no longer observed in control cells but it persisted in L2A(−) cells (Fig. 4c) . Phosphatase treatment confirmed that PLIN2 was phosphorylated during lipolysis in CTR cells but not in L2A(−) cells that accumulated a form of PLIN2 unchanged by the phosphatase (Fig. 4c) . Analysis of LDs by electrophoresis using Phos-tag (for resolution of phosphorylated variants) confirmed the presence of a phosphorylated form of PLIN2 in control cells almost completely absent in L2A(−) cells (Fig. 4d) . Although further studies are needed to elucidate the reasons for reduced levels of phospho-PLIN2 in the absence of functional CMA, our findings suggest that phosphorylation of PLIN2 may be required to trigger its CMA degradation.
CMA-resistant PLIN2 causes steatosis
Hsc70 binds CMA substrates through a pentapeptide motif 4 . PLIN3 bears a canonical CMA motif ( 100 LDRLQ) and PLIN2 a putative Representative blots of n = 3 (OL > S+) and 6 (None and OL) independent experiments. (d) PLIN2 immunoblots of total cell lysates from CTR and L2A(−) cells subjected to the indicated treatments run with Phos-tag to resolve phosphorylated proteins. Immunoblots from two independent experiments are shown. Arrows: orange (unphosphorylated PLIN2), blue (phosphorylated PLIN2). Values are mean ± s.e.m. Differences are significant for * * * P < 0.001 using Student's t-test. Unprocessed original scans of blots are shown in Supplementary Fig. 8 . Source data are available in Supplementary Table 1. motif ( 414 SLKVQ). To analyse the consequences of preventing CMA degradation of PLIN2, independently from other changes that may occur during CMA blockage, we mutated the PLIN2 CMA-targeting motif to 414 SLKAA. Expression of wild-type (WT) and CMA-mutant (MT) PLIN2-GFP in control cells led to higher levels of MT PLIN2-GFP (Fig. 5a ) and a ∼2.7-fold increase in LD content and size as compared with WT PLIN2-expressing cells under basal conditions (Fig. 5b ) and on OL challenge (Fig. 5c) . MT PLIN2-GFP accumulation was mainly due to its reduced lysosomal degradation, as treatment with lysosomal inhibitors (NL) increased WT but not MT PLIN2-GFP levels (Fig. 5c ) and, unlike for WT PLIN2, failed to increase colocalization of MT PLIN2 with the lysosomal marker LAMP1 (Fig. 5d) .
We confirmed that disruption of the CMA-targeting motif in PLIN2 almost completely abrogates its binding to hsc70 (Fig. 5e) , explaining the reduced co-localization of hsc70 with LD in cells expressing MT PLIN2 ( Fig. 5f,g ; three-dimensional (3D) reconstruction of Z-sections shown in Supplementary Fig. 4a and Supplementary Video 1). Persistence of MT PLIN2 on LDs altered their cellular dynamics and their interplay with lysosomes. Thus, livecell imaging of cells co-expressing WT PLIN2-GFP and LAMP1-RFP revealed that WT PLIN2-GFP LDs were predominantly small and very mobile as reported earlier 35, 36 ( Fig. 5h-j and Supplementary Video 2 (green channel only)) and showed dynamic inter-LD associations and kiss-and-run events between LDs and lysosomes ( Fig. 5h-j and Supplementary Video 3 (merged channels)). In striking contrast, most LDs in MT PLIN2-expressing cells formed larger, less dynamic clusters and the very few smaller LDs rarely associated with lysosomes ( Fig. 5h-j; Z-section stack shown in Supplementary  Fig. 4b and Supplementary Videos 2 and 3). In summary, preventing degradation of PLIN2 by CMA is sufficient to induce the intracellular lipid accumulation observed in CMA-deficient cells (Figs 1 and 2 ) and to reduce LD/lysosome interactions.
Defective CMA of PLINs blocks lipolysis
Triglycerides in LDs are broken down into FFA either by cytosolic lipases 21, 23 or by lysosomal lipases that gain access to these cytosolic stores through macrolipophagy 18 . To assess which lipolytic pathway failed to mobilize LDs in L2A(−) cells (Fig. 1) , we treated cells with a lipase inhibitor, diethylumbelliferyl phosphate, and with lysosomal inhibitors (NL) and found that β-oxidation decreased in control cells but L2A(−) cells remained unresponsive (Fig. 6a) . Overall these findings suggested that blocking CMA results in impaired lipolysis by cytosolic lipases and macrolipophagy.
The rate-limiting cytosolic lipase in most cell types, ATGL (ref. 21 ), co-localizes with LDs (lipid-or protein-labelled) during lipogenic stimulus (OL) and in OL > S− or OL > low-glucose S+ conditions to induce lipolysis (Fig. 6b,c and Supplementary Fig. 5a,b) . Similarly, chemical activation of CMA increased co-localization of ATGL with LDs (Fig. 6d) . In contrast, CMA-defective cells exhibited significantly reduced association of ATGL with LDs in all conditions (Fig. 6b,c and Supplementary Fig. 5a ,b) despite total ATGL levels remaining unchanged (Fig. 6e) , pointing towards defective localization of this lipase on LDs. Reduced lipolytic activity of ATGL in CMA-deficient cells could not be attributed to changes in its association with endogenous modulators because, on the contrary, pulldown for ATGL in L2A(−) cells revealed reduced binding to its inhibitor G 0 /G 1 switch gene 2 (G0S2) and enhanced association with its co-activator comparative gene identification 58 (CGI-58; Fig. 6f,g ), probably reflecting cellular compensatory efforts to sustain lipolysis. Similar changes occur in vivo as association of ATGL with rat liver LDs was enhanced on starvation, which activates both lipolysis and CMA (Fig. 6h) , but LDs isolated from livers of starved L2AKO mice 22 exhibited a discrete but consistent reduction in ATGL levels and a more pronounced decrease in levels of its co-activator CGI-58 when compared with LDs isolated from control mice ( Fig. 6i and Supplementary Fig. 5c ). Furthermore, expression of the CMAresistant PLIN2, but not the WT variant, was sufficient to significantly reduce the association of ATGL with LDs (Fig. 6j) . Thus, the inability to remove PLIN2 from LDs in CMA-deficient cells leads to reduced lipolysis, in part because it impairs the association of the cytosolic lipase ATGL with LDs.
To investigate the reasons behind reduced lysosome-dependent lipophagy in CMA-defective cells (Fig. 6a) , we first analysed changes in LD abundance on macroautophagy blockage ( Fig. 7a and Supplementary Fig. 5d ). Addition of 3-methyladenine was efficient in reducing macroautophagy in both control and L2A(−) cells ( Supplementary Fig. 5e ) but resulted in increased LD number only in control cells ( Fig. 7a and Supplementary Fig. 5d ). Similarly, upregulation of macroautophagy with rapamycin resulted in a more pronounced decrease in LD content in control than in L2A(−) cells (Fig. 7b,c) . This reduction in macrolipophagy in cells with defective CMA contrasts with the previously reported increase in nonselective macroautophagy in these cells 25 , which we also confirmed by LC3 staining (Supplementary Fig. 5f ). To investigate the reasons behind the macrolipophagy failure, we analysed the recruitment of macroautophagy proteins (ATGs) to LDs that occurs in the liver when lipolysis is activated by prolonged starvation (Fig. 7d) and also in cultured fibroblasts on OL challenge ( Supplementary Fig. 6a,b) . Coimmunostaining in L2A(−) cells revealed a significant decrease in colocalization with LDs of components of the macroautophagy initiation complex (Beclin1, ATG14, Vps15 and Vps34), proteins involved in autophagosome elongation (ATG5) and the structural autophagosome component (LC3; Fig. 7e,f and Supplementary Fig. 6c,d) . We also analysed two cargo-recognition proteins and found that LDs in L2A(−) cells show lower co-localization with NBR1 (Fig. 7e,f) , the one that normally increases on LDs during lipolysis (Fig. 7d and Supplementary Fig. 6a,b) , whereas co-localization with p62, which does not change during lipolysis, remained also unchanged in L2A(−) cells (Supplementary Fig. 6e ). Co-localization between LDs and ATG7, the ligase that mediates elongation, remained unchanged whereas other ATG proteins such as ULK1, ATG9 and UVRAG did not colocalize with LDs either in control or L2A(−) cells ( Supplementary  Fig. 6e,f) . Co-localization of Rab7 with LDs, required for lysosomemediated lipolysis 37 , was also significantly reduced in L2A(−) cells (Fig. 7g) . In vivo analysis using isolated liver LDs confirmed that levels of LC3, ATG5, Beclin1 and NBR1 were reduced in L2A-defective mice as compared with control mice (Fig. 7h) . Furthermore, even in the context of functional CMA, expression of the CMAresistant PLIN2 mutant was sufficient to significantly reduce the amount of LC3, ATG5 and Beclin1 associated with LDs ( Fig. 7i and Supplementary Fig. 7a,b and Supplementary Video 4 and 3D reconstructions of Z-sections shown in Supplementary Fig. 7c and Supplementary Video 5), confirming that inability to degrade LDassociated PLINs through CMA inhibited the association of the macroautophagy machinery with LDs. We propose that failure to anchor ATGs at the LD surface prevents initiation of macrolipophagy. Ultrastructural analysis confirmed that the membranous structures observed in large LDs in control cells on induction of lipolysis (by OL challenge or starvation) and previously proposed as a signature of macrolipophagy of portions of LDs (ref. 18) were almost completely absent in LDs of L2A(−) cells (Supplementary Fig. 7d ). Collectively, these results indicate that removal of PLINs through CMA precedes macrolipophagy.
Altogether, we propose that degradation of the LD proteins PLIN2 and PLIN3 by CMA is required for the LD association of both the cytosolic lipase and the macroautophagy effector proteins, and for subsequent lipolysis, explaining the intracellular lipid accumulation observed on CMA compromise (Fig. 8) .
DISCUSSION
In this study, we demonstrate the role of CMA in regulating mobilization of intracellular lipid stores by degrading the LD proteins PLIN2 and PLIN3. Removal of these LD proteins is a prerequisite for subsequent lipolysis to occur, because failure to remove these proteins through CMA results in decreased LD association of components of both arms of the lipolytic machinery-cytosolic lipases and macrolipophagy (Fig. 8) .
Triglycerides in LDs are broken down by cytosolic lipases to generate FFAs that undergo β-oxidation in mitochondria 21, 23 and by lysosomal lipases on sequestration of complete or fractions of LDs by macrolipophagy 18, 19 . ATGs and ATG-positive membranes are detected in LDs during lipolysis, suggesting that the autophagosome limiting * * 3 and >1 µm 3 , respectively. i: n = 24 cells from 3 independent experiments. j: n = 103 (WT) and 85 (MT) LD clusters from 6 (WT) and 8 (MT) videos with >8 cells per video from 2 independent experiments. Values are mean ± s.e.m. Differences are significant for * P < 0.05, * * P < 0.01, * * * P < 0.001 using Student's t-test. Unprocessed original scans of blots are shown in Supplementary Fig. 8 . Source data are available in Supplementary Table 1. membrane forms in situ on the LD surface. In fact, recent studies have shown that LDs are a site for autophagosome biogenesis 38 . We have uncovered that CMA is required before the selective sequestration of LDs by the autophagosome, suggesting that for ATGs to associate and initiate autophagosome biogenesis, LD peripheral proteins would have to be removed from the LD surface. Consequently, the only residual Values are mean ± s.e.m. Differences are significant for * P < 0.05, * * P < 0.01, * * * P < 0.001 using Student's t-test. Unprocessed original scans of blots are shown in Supplementary Fig. 8 . Source data are available in Supplementary Table 1. lipolysis observed in CMA-deficient cells could be attributable to inbulk macroautophagy, shown to be upregulated in these cells 25 , and where cargo recognition is not required. Values are mean ± s.e.m. Differences are significant for * * P < 0.01, * * * P < 0.001 using Student's t-test. Unprocessed original scans of blots are shown in Supplementary Fig. 8 . Source data are available in Supplementary Table 1 .
effect' that modulates the lipase's accessibility to triglycerides. In this regard, overexpression of PLIN2 reduces LD association of ATGL and hence, lipolysis 39, 40 . We propose that CMA facilitates lipolysis by removing PLINs from LDs because we found decreased association of ATGL on LDs in cells with elevated PLIN2 levels, either due to impaired CMA or due to expression of the CMA mutant. In addition, PLIN2 removal could also facilitate binding of the co-activator to ATGL already on LDs, because CMA blockage reduced levels of CGI-58 in LDs.
Although PLIN2 has been reported to be a proteasome substrate 28, 29 , both lysosomes and proteasomes can degrade the same protein depending on the cellular requirement or the cell type, as reported, for example, for PLIN1 (refs 41-43) . In our study, we observed both lysosomal and proteasomal degradation of PLIN2, but interestingly, CMA blockage also prevented PLIN2 proteasomal degradation. Although it is plausible that CMA might indirectly facilitate proteasomal degradation of PLIN2, our data disfavour this option because: PLIN2 directly interacts with hsc70; we detect PLIN2 in CMA-active lysosomes and its degradation in this compartment; and eliminating the CMA-targeting motif retains PLIN2 in LDs. We propose thus that PLIN2 is directly identified by hsc70 in LDs and targeted for CMA degradation. The proteasome may be able to access LD PLIN2 only once its removal has been initiated by CMA or, alternatively, the PLIN2 amenable to proteasomal degradation could be located in a different compartment, as described before 29 . We describe PLIN2 and PLIN3 as the first lipid-anchored proteins to be CMA substrates. The presence of hsc70 on LDs, also described before [44] [45] [46] [47] , and its persistence at the LD surface when CMA is blocked, together with the altered LD and lysosomal dynamics in these conditions, suggests the presence of a microenvironment at the LD surface, wherein lysosomes and LDs are in close proximity. Dynamic and transient LD interactions, similar to the ones we propose here with lysosomes, have been described between LDs and other organelles, such as mitochondria and peroxisomes [48] [49] [50] , to channel FFA from lipolysis to sites of oxidation 20 . Our studies with live-cell microscopy support a marked reduction in kiss-and-run events between LDs and lysosomes in conditions that compromise PLIN degradation by CMA such as mutations in the CMA-targeting motif of PLIN2 that prevent hsc70 interaction with this protein.
We thus propose that degradation of PLINs through CMA occurs in discrete areas on LDs to facilitate punctual removal of PLINs from the LD surface for ATGL and ATGs to access the stored triglycerides. ATGL rapidly cycles on and off of LDs to catalyse lipolysis 39 and, similarly, association of LC3 with LDs is polarized and occurs in discrete areas on the LD surface from where the limiting membrane starts forming 18 . Although the mechanisms that determine removal of only a fraction of PLINs in a localized region of LD require future investigation, we speculate that changes in PLIN phosphorylation may facilitate the release of a specific fraction of PLINs from LD. In fact, PLIN2 has been already identified as part of the phosphoproteome of LDs (ref. 51) .
We propose that the pronounced hepatic lipid accumulation observed in L2AKO mice results from a combination of: increased levels of lipogenic enzymes degraded through CMA (ref. 22 ), reduced VLDL secretion 22 , and reduced lipolysis due to the inability of cytosolic lipases and ATGs to bind to LDs when PLINs are not degraded by CMA. We have previously shown that chronic lipid loading inhibits CMA activity 15 . In light of our current findings of regulation of lipid stores by CMA, it is conceivable that a compromise in CMA would set up a vicious cycle of lipid overloading in cells. CMA activity decreases with age 16 , and it is plausible that changes in CMA would impact cellular lipohomeostasis and the steatosis observed during ageing, which in turn would further suppress CMA activity. Manipulating CMA could thus be a viable therapeutic option against excessive lipid accumulation.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper
Cell culture and treatments. NIH3T3 mouse fibroblasts (American Type
Culture Collection) were cultured in complete Dulbecco's modified Eagle's medium (DMEM, Sigma-Aldrich), 10% heat-inactivated newborn calf serum (HyClone), 1% penicillin/streptomycin/fungizone (Invitrogen) and maintained at 37 • C/5% CO 2 . NIH3T3 clones stably RNA-interfered for LAMP-2A (L2A(−)) were generated as described previously 25 . All of the cell lines were tested for mycoplasma contamination using a DNA staining protocol with Hoechst 33258 dye. Oleic acid (Sigma-Aldrich) was conjugated to albumin as described previously 52 , and cells were treated with 0.06 mM oleate (OL) for 24 h unless otherwise stated. Where indicated, OL was washed off with Hanks' balanced salt solution (Invitrogen) and replaced by DMEM or low-glucose DMEM with or without serum (OL > S+, OL > S+ Low Glc, OL > S−, respectively) for 16 h. Cells were treated with lysosomal inhibitors ammonium chloride (20 mM; American Bioanalyticals) and leupeptin (100 µM; Fisher Scientific), macroautophagy activator rapamycin (100 nM; Sigma-Aldrich), proteasomal inhibitors lactacystin (5 µM; Enzo Life Sciences) and MG132 (5 µM; Sigma-Aldrich), and mitochondrial depolarizer FCCP (2 µM; Sigma-Aldrich) for 16 h unless indicated otherwise. For imaging experiments, cells were treated with etomoxir (10 µM; Sigma-Aldrich) for 6 h.
Plasmids and reagents. Mouse PLIN2-tGFP and G0S2-tGFP plasmids were from
Origene, rat LAMP1-RFP plasmid was from the Addgene plasmid repository, human dsRed-LC3 plasmid 53 , mtKeima plasmid 26 and GFP-dgn/GFP-degFS (ref. 30) plasmids were as described before, and human L2A (PGK-hL2A, plasmid includes the GFP transgene, to facilitate identification of transfected cells) was generated in our laboratory 54 . Mutagenesis was performed using the QuikChange site-directed mutagenesis kit (Agilent Biotechnologies). Cells were transfected with 1 µg DNA plasmid (or 0.5 µg of each plasmid in the case of co-transfection) using Lipofectamine 2000 transfection reagent (Invitrogen) according to the manufacturer's instructions. Sources of chemicals were as previously described 18, 25, 55 .
Antibodies. The dilutions and sources of antibodies used for immunoblot (IB)
and 
Animals and treatments.
Adult Wistar male rats (25) and C57BL/6 male mice (12) (Charles River Laboratories) were used. L2A knockout mice were generated as described previously 22 . Where indicated, rats or mice were starved for 48 h or 24 h before organelle isolation by removing food but maintaining water ad libitum. Animals were injected intraperitoneally with leupeptin (2 mg per 100 g body weight) 2 h before organelle isolation. All animal studies were approved by the Institutional Animal Care and Use Committee. Randomization between control and L2AKO mice was not possible as animal group is based on genotype. In the case of starvation and treatment with vehicle or leupeptin, animals were randomly attributed to each group. The investigators were not blinded to allocation during experiments and outcome assessment. No statistical method was used to predetermine sample size.
Triglyceride measurement. Triglycerides were measured by a commercial kit (Sigma-Aldrich) according to the manufacturer's instructions.
Triglyceride synthesis. Triglyceride synthesis was measured as described before 18 . Briefly, synthesis of triglycerides derived from [
14 C]oleate (PerkinElmer) complexed with BSA was measured by incubation of untreated or OL-treated cells with [
14 C]oleate-BSA (0.2 µCi, 4 h), followed by extraction of cellular lipids and analysis by thin-layer chromatography. Incorporation of radioactivity into triglycerides was determined using a Storm Gel and Blot Imaging System (GE Healthcare) followed by densitometry using ImageJ. 
Beta-oxidation.
Rates of fatty acid beta-oxidation were determined by metabolic radioactive labelling as described earlier 18 and by respiratory measurements. Briefly, the rate of carbon dioxide production resulting from the oxidation of [ 14 C]oleate was measured. Cells pretreated with or without OL (0.06 mM) were treated with [
14 C]oleate-BSA (0.8 µCi, 4 h). Where indicated, the inhibitors ammonium chloride (20 mM) and leupeptin (100 µM), and diethylumbelliferyl phosphate (Deup) (100 µM), were added with the radiolabelled oleate for 4 h. The released [
14 C]carbon dioxide was trapped at 37 • C for 1 h onto filter paper pre-soaked in 100 mM sodium hydroxide. The rate of beta-oxidation was calculated as the amount of trapped [ 14 C]carbon dioxide in relative units produced per microgram protein per hour. Equal numbers of cells were plated in XF96 plates (Seahorse Bioscience) in low-glucose DMEM (GIBCO) supplemented with serum. Cells were treated with OL (0.12 mM) for 16 h, following which cell respiration was assayed as time-resolved measurements of oxygen consumption rate (OCR) in a respirometer (Seahorse Bioscience). Fatty acid beta-oxidation was calculated as specified by the manufacturer by injecting etomoxir (50 µM) in the buffered assay medium.
Cell imaging. For immunofluorescence microscopy, cells grown on coverslips were fixed with 4% paraformaldehyde (or pre-chilled methanol in the case of staining for Hsc70, to highlight the membrane-associated protein) for 30 min, permeabilized and blocked with 1% BSA, 0.01% Triton X-100 in phosphate buffer saline (PBS). Incubation with primary and secondary antibody conjugated to Alexa Fluor 488 or Cy5 (Invitrogen) in 0.1% BSA in PBS was performed at room temperature for 1 h each. For LD staining, cells were incubated with BODIPY 493/503 (Invitrogen, 20 µg ml −1 ) or 1,6-diphenyl-1,3,5-hexatriene (DPH, Sigma-Aldrich, 5 µM; pseudocoloured to red or green) for 20 min at 37 • C before fixation. For mitochondria staining, cells were incubated with MitoTracker (50 mM) and MitoTracker CMXRos (50 nM; Invitrogen) for 20 min 37 • C before fixation. Coverslips were mounted in DAPI-Fluoromount-G (Southern Biotechnology) or Draq5 (Invitrogen; pseudocoloured to blue) to stain the nucleus. All images were acquired with an Axiovert 200 fluorescence microscope (Carl Zeiss Microscopy) with a ×63 objective and 1.4 numerical aperture, mounted with an ApoTome.2 slider, and prepared using Adobe Photoshop CS3 (Adobe Systems) and ImageJ (NIH). Where indicated, cells plated in glass-bottom 96-well plates were treated, stained with BODIPY493/503, fixed and images were acquired using a high-content microscope (Operetta, Perkin Elmer). Images of 9 different fields per well were captured, resulting in an average of 1,500-2,000 cells. Nuclei and puncta were identified using the manufacturer's software. The number of particles/puncta per cell was quantified using the 'analyse particles' function of ImageJ after thresholding in non-saturated images. The percentage of co-localization was determined by the 'JACoP' plugin in ImageJ after thresholding of individual frames 56 . Where indicated, the co-localized pixels were highlighted using the 'co-localization' plugin of ImageJ. Three-dimensional reconstruction images were modelled from Z-sections as mixed renderings using the Inside4D module for AxioVision Rel. 4.8. after applying the Nyquist-Shannon sampling theorem. Immunofluorescence and direct fluorescence quantifications of the number of lipid droplets, number of puncta and percentage co-localization were performed blinded.
Live-cell imaging was performed in cells grown in glass-bottom dishes (MatTek) 24 h post-transfection (with 8 h OL treatment) at 37 • C in a CO 2 -enriched atmosphere in recording medium (phenol red-free DMEM (GIBCO), 3.7 mg ml −1 NaHCO 3 , and 25 mM HEPES, pH 7.4) using a 4D spinning-disc confocal microscope (PerkinElmer, TE2000S) with a ×60 NA 1.4 oil objective and ORCA-ERA camera (Hamamatsu). Images were acquired as a stack of 40-50 Z optical planes (0.4 µm) encompassing the entire cell width at a fixed rate of maximum speed for ∼20 min. Image sequences were processed with Volocity and ImageJ. Using Volocity, small and large LD clusters were identified as <1 µm 3 and >1 µm 3 , respectively, and were tracked using the software to calculate the displacement (straight line distance between the start and the end point of the track), displacement rate (displacement/(time of last time point in the track-time of the first time point of the track)) and tracking velocity (average speed over the whole track).
For electron microscopy, cells were fixed with 2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M sodium cacodylate buffer pH 7.4 at 4 • C for 3 h. Postfixation with 1% osmium tetroxide was followed by dehydration with graded series of ethanol, infiltration and embedding in EMbed 812 (Electron Microscopy Sciences). Sections (80 nm) were cut with an ultramicrotome (Leica), stained with uranyl acetate followed by lead citrate and viewed in a JEM-1200EX transmission electron microscope (JEOL) at 80 kV. Morphometric analysis was done using ImageJ with LDs identified as electron translucent structures lacking surrounding membrane. Micrographs were independently annotated by two people and the average of their scoring was used for each micrograph.
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Cellular subfractionation. Rat liver lysosomes were isolated from a light mitochondrial-lysosomal fraction by centrifugation in a discontinuous metrizamide density gradient 57 . Rat and mouse liver LDs were isolated as described previously 18 . Livers homogenized in 0.25 M sucrose were centrifuged at 6,800g for 5 min at 4 • C. The supernatant and the fatty layer were centrifuged at 17,000g for 10 min at 4 • C to pellet lysosomes. The supernatant was adjusted to 20% sucrose (LD-enriched fraction) and centrifuged in a discontinuous sucrose density gradient at 28,000g for 60 min at 4 • C. The LD fraction collected was delipidated, solubilized in SDS, and an equal protein amount was analysed by immunoblot.
Co-immunoprecipitation. Co-immunoprecipitation was performed in total cell lysates or LD-enriched fractions prepared in 25 mM Tris (pH 7.2), 150 mM NaCl, 5 mM MgCl 2 , 0.5% NP-40, 1 mM dithiothreitol, 5% glycerol and protease inhibitors using standard procedures. An equal protein amount of each fraction was incubated with primary antibody (1 µg) overnight followed by incubation with protein Aconjugated Sepharose for 1 h, centrifugation and washes.
General methods. Total cell lysates were prepared in RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% NaDoc, 0.1% SDS, 50 mM Tris pH 8) containing protease and phosphatase inhibitors. Protein concentration was measured using bovine serum albumin as a standard 58 . Isoelectric focusing (IEF) was done using the Protean IEF Cell (Bio-Rad) at 20 • C with rapid ramping to voltage 10,000 V at a current limit of 50 µA using IPG Strips with 4-7 pH range (Bio-Rad). Where indicated, total cellular fractions were treated with λ-phosphatase according to the manufacturer's instructions (New England BioLabs) before IEF. Phos-tag PAGE was performed according to the manufacturer's instructions (Wako) using 100 µM Phostag. Samples were subjected to SDS-PAGE, transferred to nitrocellulose membrane, blocked with low-fat milk and incubated with primary antibody overnight. The proteins were visualized by using peroxidase-conjugated secondary antibodies and chemiluminescent reagent (PerkinElmer) in a LAS-3000 Imaging System (Fujifilm). Densitometric quantification was performed on unsaturated images using ImageJ.
Sample size, randomization and statistical analyses. In the studies performed in cell lines in culture, all experiments were repeated at least 3 times and often with duplicate blots in the same experiment. All numerical results are reported as mean ± standard error of the mean (s.e.m.). Statistical significance of the difference between experimental groups was analysed by two-tailed unpaired Student's t-test using MS Excel. Differences were considered statistically significant for P < 0.05. For those experiments in which an estimate of variation was possible based on previous studies or published work by others, we have confirmed that the variance is similar between the control and experimental groups compared. For those instances in which previous information was not available, we have made a comparison with other conditions in which changes in cellular components resulted in changes in CMA. Kaushik and Cuervo Suppl. Values are mean ± SEM. Differences are significant for *P<0.05, **P <0.01, ***P<0.001 using Student's t-test. Source data is available in Supplementary Table 1 . Insets on the right show details of different morphological features previously attributed to macrolipophagy 18 and that include: LD (blue arrows; no limiting membrane); where a limiting membrane appears to be forming on the LD surface (yellow arrows); vesicles (putative autolysosomes) containing cargo compatible with lipids (red arrows; limiting membrane) and LD with membranes that originate from their surface toward the core of the LD (green arrows), previously described to correspond to LC3-positive limiting membranes 1 . Micrographs originate from 3 independent experiments. Values are mean ± SEM. Differences are significant for ***P<0.001 using Student's t-test. Source data is available in Supplementary Table 1. 
